Organogenesis Holdings Inc.

Healthcare

NASDAQ:ORGO · NASDAQ Capital Market

Market Cap $306.25M Beta 1.33 P/E (TTM) -1053.0

$2.34 -1.68%

-$0.04 today

52W Low $2.04High $7.08

Vol 0.76M · Avg 1.48M

EPS (TTM)-$0.00

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-23.78%

Period High

$6.54

Period Low

$2.24

Latest

$2.34

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Esperion Therapeutics, Inc.

NASDAQ:ESPR

$654.91M

AngioDynamics, Inc.

NASDAQ:ANGO

$499.96M

Varex Imaging Corporation

NASDAQ:VREX

$464.78M

Evolus, Inc.

NASDAQ:EOLS

$443.20M

Emergent BioSolutions Inc.

NYSE:EBS

$429.28M

Monopar Therapeutics Inc.

NASDAQ:MNPR

$400.40M

SNDL Inc.

NASDAQ:SNDL

$369.44M

SIGA Technologies, Inc.

NASDAQ:SIGA

$309.85M

Bicycle Therapeutics plc

NASDAQ:BCYC

$281.05M

Compass Therapeutics, Inc.

NASDAQ:CMPX

$280.72M

What is the latest ORGO filing?

The latest filing shown is 8-K dated May 7, 2026.

How many recent filings does ORGO have?

Intrinsic Alpha currently shows 20 recent filings for ORGO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.